Regardless of what broader uses may be on the horizon, hospitals and health systems will need to evaluate how these medications change patient risk factors and current treatments and provide wrap-around services for patients who use these medications.
Concerns that require attention: carpal tunnel-style tingling (signals excessive GH/IGF-1), elevated fasting glucose, persistent joint pain, and rare immunogenicity reactions
The weighted-average assumptions used to value employee and non-employee stock option awards granted during the years ended December 31, 2025 and 2024, using the Black-Scholes option pricing model, were as follows: The weighted-average assumptions used to value employee stock purchase plan shares granted during the year ended December 31, 2025, using the Black-Scholes option pricing model, were as follows: F-27 Stock-based Compensation Expense Stock-based compensation expense for restricted stock awards, stock options, and ESPP recognized in the Companys statements of operations and comprehensive loss is presented as follows (in thousands): As of December 31, 2025, total unrecognized stock-based compensation expense related to unvested restricted stock awards, stock options, and ESPP was $ 11
The FDA wont touch those labs
This allows serums and lightweight formulas to be absorbed into the skin without struggling to go through thicker formulations
Our offerings are very simple - compounded GLP-1s
